• Tue. May 28th, 2024

Medication Abortion Under Threat: The Consequences of Overturning FDA’s Approval for Mifepristone

BySamantha Nguyen

Mar 27, 2024
Health experts worried about potential limitations on abortion pill access by Supreme Court.

Mifepristone, a combination of drugs approved by the FDA for medication abortion, is currently under threat of being overturned by the Supreme Court. This move has sparked concerns among experts like Harry Nelson, a health care attorney, who views the idea of courts overriding the FDA as a drastic and radical step.

Mifepristone and misoprostol are specifically designed as a one-dose pill for patients up to 10 weeks pregnant, impacting the hormone progesterone crucial in menstruation and pregnancy. Over two decades of research and more than 100 peer-reviewed publications support the safety and effectiveness of medication abortion, according to Ushma Upadhyay, a public health scientist.

Apart from its use in medication abortions, mifepristone also serves other medical purposes such as treating miscarriages, uterine fibroids, and Cushing’s syndrome. Without access to mifepristone, patients may have to resort to riskier options like taking misoprostol alone or undergoing surgical procedures. This underscores the importance of maintaining access to mifepristone for a variety of reproductive health care needs.

The potential repercussions of the Supreme Court’s decision extend beyond just abortion access, as it could disrupt the drug approval process and limit people’s access to safe medications. Recent research reveals a significant increase in self-managed medication abortions following the overturn of Roe v. Wade, highlighting the importance of ensuring access to safe and legal reproductive health care options. Telehealth abortion services have also emerged as a crucial resource for patients in need of time-sensitive care, especially considering the FDA’s restrictions on the use of mifepristone up to 10 weeks.

If this move is successful in reversing changes made in 2016 that aimed to make it more accessible to patients then it will be detrimental not only to women seeking an abortion but also those who require it for other medical conditions.

In conclusion, overturning FDA’s approval for mifepristone would be disastrous not only for women seeking an abortion but also those requiring it for other medical conditions. It is important that we maintain access

By Samantha Nguyen

As a content writer at newsqwe.com, I am passionate about crafting engaging and informative articles that captivate our audience. With a background in journalism and a keen eye for detail, I strive to deliver content that is not only well-researched but also adds value to our readers' lives. From breaking news stories to in-depth features, I take pride in my ability to tell compelling stories that resonate with our diverse audience. When I'm not typing away at my keyboard, you can find me exploring new cafes, practicing yoga, or getting lost in a good book. I am thrilled to be a part of the newsqwe.com team and look forward to sharing my love for writing with all of our readers.

Leave a Reply